Edward Carraway, MD
Interventional Cardiology · Tuscaloosa, ALNPI 1114139300
Payments from drug & device makers
Across 588 payments — averaging $14.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$2K
- Actelion Pharmaceuticals US, Inc.$1K
- Johnson & Johnson$740
- Amgen$563
- Abbott$377
- Sanofi-aventis U.S. LLC$333
- plus $3K from 33 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 228 | $2,344 |
| Actelion Pharmaceuticals US, Inc. | 86 | $1,312 |
| Johnson & Johnson | 59 | $740 |
| Amgen | 44 | $563 |
| Abbott | 15 | $377 |
| Sanofi-aventis U.S. LLC | 19 | $333 |
| Angiodynamics, Inc. | 4 | $275 |
| Medtronic(2 entities) | 5 | $255 |
| Philips North America LLC | 8 | $222 |
| United Therapeutics Corporation | 16 | $185 |
| Novo Nordisk | 8 | $169 |
| Gilead | 12 | $155 |
| Bard Peripheral Vascular, Inc. | 5 | $148 |
| Boehringer Ingelheim | 7 | $137 |
| Amarin Pharma, Inc. | 9 | $131 |
| Pfizer | 8 | $122 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 8 | $118 |
| Merck | 5 | $102 |
| Lundbeck LLC | 4 | $97 |
| AstraZeneca | 6 | $76 |
| Bayer | 5 | $74 |
| Esperion Therapeutics, Inc. | 3 | $65 |
| Chiesi USA, Inc. | 4 | $64 |
| Cardiovascular Systems Inc. | 3 | $47 |
| Kiniksa Pharmaceuticals International, PLC | 2 | $42 |
| Inari Medical, Inc. | 2 | $39 |
| Convatec Inc. | 1 | $30 |
| Regeneron Healthcare Solutions, Inc. | 1 | $25 |
| Irhythm Technologies, Inc. | 1 | $24 |
| Cleerly, Inc. | 1 | $19 |
| GSK | 1 | $16 |
| Scpharmaceuticals Inc. | 1 | $15 |
| Alnylam Pharmaceuticals Inc. | 1 | $14 |
| Terumo Medical Corporation | 1 | $13 |
| Boston Scientific | 1 | $13 |
| Shockwave Medical, Inc | 1 | $12 |
| E.r. Squibb & Sons, L.L.C. | 1 | $12 |
| Akcea Therapeutics, Inc. | 1 | $12 |
| Kowa Pharmaceuticals America, Inc. | 1 | $11 |
How this compares
$8,408 in reported general payments places this provider in the 45th percentile of 109 interventional cardiology providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other interventional cardiology in Tuscaloosa
- George HemstreetTuscaloosa$35K
- John LedouxMobile$2.3M
- Alejandro VasquezHuntsville$1.2M
- Michael ButlerHuntsville$919K
- Robert FosterBirmingham$553K
- Chad AlfordMobile$461K
- Mihir KanitkarHuntsville$394K
- Brigitta BrottBirmingham$376K
- Pochana ReddyHuntsville$293K
- Kevin DeandradeMobile$239K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.